Interpace Diagnostics has scored a reimbursement win from the Blue Cross Blue Shield federal program for its ThyGeNEXT and ThyraMIR thyroid cancer tests.
BCBS federal program to cover Interpace Dx's thyroid cancer tests
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.